Novo Nordisk announces expansion of Hillerød API manufacturing facility
Novo Nordisk will invest 15.9 billion Danish kroner into the expansion of their existing API manufacturing facility.
Novo Nordisk have announced on June 12, 2023 that they are to invest DKK 15.9 billion kr. for the expansion of their API manufacturing facility in Denmark for products that treat serious chronic diseases, such as diabetes.
The current production facility, located in Hillerød, Denmark, will benefit from the investment with increased production capacity and enable the Danish pharmaceutical company to meet market demands in the future regarding drug products for chronic diseases. The facility will particularly develop Novo Nordisk’s ability to develop a clinical late-phase product portfolio in the future.
An additional 65,000 m2 will be added to design a multi-product facility and house state-of-the-art technology to ensure flexibility in accommodating new processes. The new facility will be geared towards delivering high-quality drug products compliant with environmental sustainability regulations through the use of compact and optimal process flow that reduce the consumption of water and energy. Construction has already begun, with the facility to start producing APIs by 2029, creating 340 new jobs within the region.
Henrik Wulff, Executive VP of Product Supply, Quality & IT at Novo Nordisk, highlighted the importance of the investment and the healthcare opportunities that can be provided with the right infrastructure: “This important investment will ensure the continuous development of our late-phase pipeline into deliveries of important medicines for treatments to patients worldwide,” he commented. “The investment announced today confirms Hillerød and Denmark as cornerstones in our global footprint, and I would like to take this opportunity to thank the Danish Government and Parliament for their continued focus on ensuring good and stable infrastructure and supplies – allowing us to continue to expand our production capacity to the benefit of patients living with serious chronic diseases.”
Source: Novo Nordisk invests DKK 15.9 bn in expansion of manufacturing facilities in Hillerød, Denmark [Accessed June 12, 2023] https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=166116
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: Bridging Science, Strategy, and Equity in Chemicals and Pharma
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News CPHI Podcast Series: Pharmapack special – Delivering innovation for patient outcomes
This special Pharmapack episode of our podcast, recorded live at Pharmapack 2026, interviews Terence O’Hagan, Vice President of Business Development for Drug Delivery Systems at Stevanato Group, sharing exclusive insights into the company’s... -
News Where Pharma Innovation Takes the Spotlight: Pharmapack Awards 2026
The 2026 Pharmapack Awards, held January 21, 2026, celebrated and recognised leading companies in the pharmaceutical packaging sector paving the way for packaging and drug delivery excellence in the future.
-
News Pharmapack 2026 - From the Floor
Celebrating its 25th anniversary in the city where it all started, Pharmapack 2026 is back in Paris! From January 21-22, 2026, Paris Expo Porte de Versailles opens its doors again to the pharmaceutical packaging and drug delivery sectors, ready for 2 d... -
News Driving Sustainability with Citeo PRO: An Exclusive Interview
Citeo PRO is transforming professional packaging with innovative solutions, collective action, and a dedication to sustainability within the pharmaceutical sector. Discover how they are supporting companies at Pharmapack 2026 in this interview with Dom... -
News Pharmapack's Silver Jubilee: Celebrating 25 Years of Packaging Innovation
For 25 years, Pharmapack has been at the forefront of innovation, collaboration, and progress in the pharmaceutical packaging and drug delivery industry. From its humble beginnings to becoming a global hub for industry leaders, the event has witnessed ... -
News Shaping the future of self-injection: Ypsomed's innovations at Pharmapack's 25th anniversary
Pharmapack 2026 marks a significant milestone as it celebrates its 25th anniversary, bringing together global leaders in pharmaceutical packaging and drug delivery. In this exclusive interview, Ypsomed, a pioneering developer and manufacturer of subcut...